ABNX — Abionyx Pharma SA Share News
0.000.00%
Last trade - 00:00- €62.99m
- €51.30m
- €4.06m
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls
France's ABIONYX Pharma Q1 revenue dips
Brief: ABIONYX Pharma Q1 Revenue EUR 0
France's ABIONYX Pharma 2025 revenue falls, net loss widens
Brief: ABIONYX Pharma FY Operating Cash Flow EUR -2.9 Million
French and Benelux stocks-Factors to watch 21 Nov
Brief: Abionyx Pharma And Sebia Announces Partnership To Transform Sepsis Diagnosis
Brief: ABIONYX Pharma H1 Net Income EUR -2.3 Million
Brief: ABIONYX Pharma H1 Operating Cash Flow EUR -1.87 Million
Brief: ABIONYX Pharma FY EBIT EUR -3.4 Million
Brief: Abionyx Pharma FY Revenues EUR 4.6 Mln, Down Vs EUR 5.3 Mln Yr Ago
Brief: Abionyx Pharma- Results From Phase 3 Of Apoa-I Study Are Positive For Co
Brief: Abionyx Pharma Acknowledges Phase 3 Aegis-II Study Did Not Meet Primary Efficacy Endpoint Of Mace Reduction At 90 Days
Brief: Abionyx Pharma Manufactures Third Batch Of Recombinant Human ApoA-I CER-001 With New Industrial Bioprocess
Brief: Abionyx Pharma: New Positive Results In Ophthalmology For First Class Of CER-001-Based Biomedicines
Brief: Abionyx Pharma Cash Position For Q3 At EUR 1.7 Mln